On January 16, 2026, the United States Supreme Court agreed to hear Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (No. 24-889), 1 a case that will directly shape the future of generic drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results